EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Prevalance of hepatitis B and hepatitis C infection in Leprosy patients

Emin ALTIPARMAK ¹ , Mukadder KOÇAK ² , Nihal KUNDAKÇI ² , Yasemin KOŞAR ¹ , Buket PENÇE ² , Burhan ŞAHİN ³ , Gülay TEMUÇİN ⁴

Author Affiliation(s)

1.

Türkiye yüksek İhtisas Hastanesi Gastroenteroloji Kliniği, Ankara

2.

Ankara Üniversitesi Tıp Fakültesi, Lepra Eğitim ve Araştırma Merkezi, Ankara

3.

Department of Gastroenterology, Türkiye Yüksek İhtisas Hospital, Ankar

4.

Türkiye Yüksek İhtisas Hastanesi Gastroenteroloji Anabilim Dalı, Ankara

Turk J Gastroenterol 1999; 10: 253-255

Keywords : Lepra, HBsAg, anti-HCV, Leprosy

Read: 1219 Published: 25 July 2019

Volume 10, Issue 3, September 1999

Previous Article